- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Alnylam scolded over promotional activity after Pfizer complaint | ||
| 18.06. | FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition | ||
| 18.06. | Why a deviation investigation still takes two weeks in the age of AI | ||
| 18.06. | Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma | ||
| 18.06. | Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix | ||
| 18.06. | Amid industry's cell therapy automation push, Cellares and Ori dominate the field: report | ||
| 17.06. | 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line | ||
| 17.06. | Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer | ||
| 17.06. | GSK runs first DTC ad for would-be asthma blockbuster Exdensur | ||
| 17.06. | Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports | ||
| 17.06. | Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility | ||
| 17.06. | After FDA sign-off, Colorado's drug import plan faces tough road ahead | ||
| 16.06. | FDA, UK drug regulator deepen transatlantic ties with new liaison program | ||
| 16.06. | DeepIntent gives Helix an AI twist to help marketers query data | ||
| 16.06. | Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom | ||
| 16.06. | Recipharm channels 'multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand | ||
| 16.06. | Stealth BioTherapeutics removes cloak to become Mighty | ||
| 16.06. | PhRMA talks up the power of 'Medicines First' in new campaign | ||
| 15.06. | Germany backs off plan to install variable discount pricing on drugs: report | ||
| 15.06. | Merck's Welireg-Keytruda pairing sticks the landing in adjuvant kidney cancer treatment with new FDA nod | ||
| 15.06. | IQVIA taps AI to put overlooked prescribers on marketers' maps | ||
| 15.06. | Sanofi, once on FDA course for speedy approval, gains late expansion for Tzield | ||
| 15.06. | Eisai snares government manufacturing grant as it brings Leqembi packaging to UK with $65M expansion | ||
| 12.06. | FDA hearing on Amgen's Tavneos will include findings from an independent review | ||
| 12.06. | In latest twist in Zepzelca saga, Jazz and PharmaMar lung cancer drug fails phase 3 test |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.